arrow_back Back Filing freshness 10-Q FY 2023 SEC EDGAR

download Export Data

AXIM BIOTECHNOLOGIES, INC.

AXIM

— Price unavailable

11 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bullish

auto_awesome

Analytical Summary

AXIM BIOTECHNOLOGIES, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth 345.3% ↗

Op. Margin —

ROIC 35.9% ↘

FCF / Share —

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

11-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$39.52K

↑ +345.3% —

Net Income Profit after all expenses

$-8.06M

↓ -29.1% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns ↑

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2017 10-K ↗	FY 2019 Dec 31, 2016 10-K ↗	FY 2018 Dec 31, 2015 10-K ↗	FY 2017 Dec 31, 2014 10-K ↗	FY 2016 Dec 31, 2013 10-K ↗	FY 2015 Dec 31, 2012 10-K ↗	FY 2014 Dec 31, 2011 10-K ↗	FY 2013 Dec 31, 2010 10-K ↗
Revenue Growth YoY (%)	345.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4216%)	-85.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1167%)	27.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+239%)	1.1% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-86%)	-4.2% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-153%)	—	—	—	433.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5317%)	—	—
EPS Growth YoY (%)	N/M	-66.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-29.1% Weak ↑ Weak Improving Year-over-year change in net income	61.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-284.6% Weak ↑ Weak Improving Year-over-year change in net income	28.3% Excellent ↑ Excellent Improving Year-over-year change in net income	42.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-1631.3% Weak ↓ Weak Declining Year-over-year change in net income	-553.4% Weak ↓ Weak Declining Year-over-year change in net income	-350.6% Weak Weak Year-over-year change in net income	-608.6% Weak Weak Year-over-year change in net income	—	—
Revenue CAGR 3Y (%)	-6.0% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-42.7% Weak Weak Compound annual revenue growth over 3 years	7.2% Fair Fair Compound annual revenue growth over 3 years	—	—	-2.7% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—
Revenue CAGR 5Y (%)	-4.3% Weak Weak Compound annual revenue growth over 5 years	—	—	-2.3% Weak Weak Compound annual revenue growth over 5 years	36.3% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2017 10-K ↗	FY 2019 Dec 31, 2016 10-K ↗	FY 2018 Dec 31, 2015 10-K ↗	FY 2017 Dec 31, 2014 10-K ↗	FY 2016 Dec 31, 2013 10-K ↗	FY 2015 Dec 31, 2012 10-K ↗	FY 2014 Dec 31, 2011 10-K ↗	FY 2013 Dec 31, 2010 10-K ↗
Effective Tax Rate (%) (%)	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	-37.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-409%)	-27.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-333%)	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	47.1% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	40.4% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.13x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.33x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.16x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.22x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.15x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-1.27x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-1.45x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2017 10-K ↗	FY 2019 Dec 31, 2016 10-K ↗	FY 2018 Dec 31, 2015 10-K ↗	FY 2017 Dec 31, 2014 10-K ↗	FY 2016 Dec 31, 2013 10-K ↗	FY 2015 Dec 31, 2012 10-K ↗	FY 2014 Dec 31, 2011 10-K ↗	FY 2013 Dec 31, 2010 10-K ↗
Return on Invested Capital (%)	35.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	96.4% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	597.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	—	158.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	592.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	87.1% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-66.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-110.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-262.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-143.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-259.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-796.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-68.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	105.3% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+602%)	129.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+763%)	—	—	245.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1533%)	—	100.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+569%)	95.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+533%)	—	-27.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-283%)	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2017 10-K ↗	FY 2019 Dec 31, 2016 10-K ↗	FY 2018 Dec 31, 2015 10-K ↗	FY 2017 Dec 31, 2014 10-K ↗	FY 2016 Dec 31, 2013 10-K ↗	FY 2015 Dec 31, 2012 10-K ↗	FY 2014 Dec 31, 2011 10-K ↗	FY 2013 Dec 31, 2010 10-K ↗
Interest Coverage (x)	-19.65x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-33.23x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-99.54x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-10.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-13.63x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-232.52x Weak Weak Operating income divided by interest expense Optimal: > 5x	-15.55x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	—	$-47.28K	$-452.96K	$-2.05M	—	—	$-661.13K	$-127.00	$-19.13K	$-23.14K	$0.00
Debt / EBITDA (x)	—	—	—	-0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—

📊 What does each share earn? 3 metrics

Metric	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2017 10-K ↗	FY 2019 Dec 31, 2016 10-K ↗	FY 2018 Dec 31, 2015 10-K ↗	FY 2017 Dec 31, 2014 10-K ↗	FY 2016 Dec 31, 2013 10-K ↗	FY 2015 Dec 31, 2012 10-K ↗	FY 2014 Dec 31, 2011 10-K ↗	FY 2013 Dec 31, 2010 10-K ↗
Basic EPS, GAAP (USD)	$-0.04	$0.04	$0.12	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-0.03	$-0.03	$-0.02	—	$-0.05	$-0.04	$-0.02	$-0.00	$-0.00	$0.00	$0.00
Tangible Book Value per Share (USD)	$-0.03	$-0.03	$-0.02	—	$-0.05	$-0.04	$-0.02	$-0.00	$-0.00	$0.00	$0.00

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2017 10-K ↗	FY 2019 Dec 31, 2016 10-K ↗	FY 2018 Dec 31, 2015 10-K ↗	FY 2017 Dec 31, 2014 10-K ↗	FY 2016 Dec 31, 2013 10-K ↗	FY 2015 Dec 31, 2012 10-K ↗	FY 2014 Dec 31, 2011 10-K ↗	FY 2013 Dec 31, 2010 10-K ↗
Working Capital (USD)	$-5.82M	$-3.29M	$-1.94M	$-5.59M	$-1.64M	$-1.36M	$-580.72K	$-147.61K	$-98.39K	$-38.96K	—
Total Equity (USD)	$-7.66M	$-4.83M	$-2.34M	—	$-2.37M	$-1.70M	$-580.72K	$-93.92K	$-4.70K	$10.21K	$0.00

📋 What is driving earnings? 4 metrics

Metric	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2017 10-K ↗	FY 2019 Dec 31, 2016 10-K ↗	FY 2018 Dec 31, 2015 10-K ↗	FY 2017 Dec 31, 2014 10-K ↗	FY 2016 Dec 31, 2013 10-K ↗	FY 2015 Dec 31, 2012 10-K ↗	FY 2014 Dec 31, 2011 10-K ↗	FY 2013 Dec 31, 2010 10-K ↗
Sales/Revenue/Turnover (USD)	$39.52K	$8.88K	$60.46K	$47.57K	$47.06K	$49.14K	$0.00	—	$53.33K	$10.00K	—
Depreciation Expense (USD)	$32.57K	$31.68K	$27.78K	$3.36K	$3.36K	$1.12K	$0.00	—	—	—	—
Net Income, GAAP (USD)	$-8.06M	$-6.24M	$-16.03M	$-4.17M	$-5.81M	$-10.09M	$-582.95K	$-89.22K	$-19.80K	$-2.79K	—
Operating Cash Flow (USD)	$-1.03M	$-2.04M	$-2.49M	—	$-1.29M	$-1.54M	$-339.00K	$-33.02K	$25.14K	$4.04K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 44 quarters

AXIM BIOTECHNOLOGIES, INC.

Analytical Summary

11-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AXIM with peers